HOSPICES CIVILS DE LYON
Clinical Trials
1.9k
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (991 trials with phase data)• Click on a phase to view related trials
Alpha tACS for Disorders of Consciousness : a Single Case Experimental Design
- Conditions
- Disorder of Consciousness
- First Posted Date
- 2025-10-09
- Last Posted Date
- 2025-10-09
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 5
- Registration Number
- NCT07213869
- Locations
- 🇫🇷
Post-Intensive Care Neurorehabilitation Unit (Service de Reeducation Post-Reanimation) in Pierre Wertheimer Neurologic Hospital, Bron, France
Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment
- Conditions
- Obesity &Amp; OverweightDigestive Disorders
- First Posted Date
- 2025-10-08
- Last Posted Date
- 2025-10-08
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 50
- Registration Number
- NCT07213323
- Locations
- 🇫🇷
Hôpital Lyon Sud, Pierre-Bénite, France
CavatermTM for Idiopathic Functional Menometrorraghia
- Conditions
- Cavaterm™ System
- First Posted Date
- 2025-10-03
- Last Posted Date
- 2025-10-03
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 20
- Registration Number
- NCT07205146
- Locations
- 🇫🇷
Hôpital Femme Mère Enfant, Lyon, France
Design of a Food Preference Assessment Tool for Older Patients in Geriatrics units_DYSPHAGING-PREFERENCES
- Conditions
- Hospitalisation in GeriatricsSwallowing DisorderEating Habits
- First Posted Date
- 2025-10-03
- Last Posted Date
- 2025-10-03
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 209
- Registration Number
- NCT07205354
- Locations
- 🇫🇷
Hopital Pierre GARRAUD Unité de Soins Médicaux et de Réadaptation, Lyon, France
🇫🇷Groupement hospitalier Sud Court Séjour de Gériatrie, Pierre-Bénite, France
🇫🇷Groupement hospitalier Sud Unité de Soins Médicaux et de Réadaptation, Pierre-Bénite, France
Is CYP24A1 Heterozygosity a Risk Factor for Nephrolithiasis?
- Conditions
- Nephrolithiasis
- Interventions
- Biological: Supplementary blood samples for PBMC analysis at V2
- First Posted Date
- 2025-10-01
- Last Posted Date
- 2025-10-01
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 45
- Registration Number
- NCT07201701
- Locations
- 🇫🇷
Hôpital Femme Mère Enfant, Bron, France
🇫🇷Hôpital Edouard Herriot, Lyon, France
- Prev
- 1
- 2
- 3
- 4
- 5
- 349
- Next
News
Volition's Nu.Q® Cancer Test Shows Promise in Lung Cancer Screening and Pan-Cancer Detection
Volition has enrolled the first patient in a 500-patient validation study at National Taiwan University Hospital to evaluate Nu.Q® Cancer technology for distinguishing between malignant and benign pulmonary nodules in LDCT lung cancer screening.